We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App





bioMérieux Showcases State-Of-The-Art Data and Connectivity Tools

By LabMedica International staff writers
Posted on 03 Feb 2025

bioMérieux (Marcy l'Etoile, France) is showcasing its latest innovations at Medlab Middle East 2025 that are designed to support the timely delivery of results for impacting patient therapy. More...

Stopping the spread of resistant organisms means ensuring patients get the right dose at the right time. bioMérieux offers a one-stop-shop to provide critical diagnostic results the length of the antimicrobial resistance (AMR) patient pathway from therapy initiation to optimization to discontinuation. At the 2025 edition of Medlab Middle East, bioMérieux is exhibiting the VITEK® MS PRIME new-generation mass spectrometry microbial identification system. VITEK® MS PRIME combines microbiology expertise with innovation, taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care. Alongside, bioMérieux is presenting the newest addition to its Sepsis Solution, VITEK® REVEAL™ which offers rapid antimicrobial susceptibility testing (AST) results to effectively and efficiently manage bloodstream infections

bioMérieux is also showcasing its stackable benchtop automated immunoassay solution, VIDAS® KUBE™ that is designed to preserve everything labs appreciate about the VIDAS® Solution combined with advanced technology. VIDAS® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence. VIDAS® KUBE™ adaptable automation helps labs be more productive, more accurate, and more innovative – all in one simplified platform. Scaling with ease, VIDAS® KUBE™ is a simple and reliable addition to evolving labs, offering smart innovations that are both time- and cost-saving.

bioMérieux is contributing to the fight against AMR by expanding syndromic testing technology outside traditional clinical laboratories to the point-of-care settings to provide patients with fast answers, while giving clinicians the information they need to make timely, targeted treatment decisions. Among its solutions are BIOFIRE® FIREWORKS™ and BIOFIRE® SPOTFIRE® Respiratory Panels for providing access to a centralized data management web portal to give users total insights and analytics into BIOFIRE® System performance, utilization, pathogen surveillance, workflow management, and more. Also featuring at the event is the BIOFIRE® SPOTFIRE® System, the latest advancement in molecular infectious disease diagnostics from bioMérieux, with all of its expertise and cutting-edge FILMARRAY® technology at the heart of the system design.


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image Credit: Adobe Stock

New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients

Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.